This short review aims to summarize our viewpoints on the mechanisms influencing osteoporosis or skeletal tissue loss in SCI via enolase-mediated inflammation and promotion of the receptor activator of nuclear factor-κB (RANK) pathway, a modulator for osteoclastogenesis and bone resorption. Here, TNFRSF11A is linked to osteoporosis.